Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL

The acquisition of genetic abnormalities engendering oncogene dysregulation underpins cancer development. Certain proto-oncogenes possess several dysregulation mechanisms, yet how each mechanism impacts clinical outcome is unclear. Using T-cell acute lymphoblastic leukemia (T-ALL) as an example, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Charlotte, Touzart, Aurore, Simonin, Mathieu, Tran-Quang, Christine, Hypolite, Guillaume, Latiri, Mehdi, Andrieu, Guillaume P., Balducci, Estelle, Dourthe, Marie-Émilie, Goyal, Ashish, Huguet, Françoise, Petit, Arnaud, Ifrah, Norbert, Baruchel, André, Dombret, Hervé, Macintyre, Elizabeth, Plass, Christoph, Ghysdael, Jacques, Boissel, Nicolas, Asnafi, Vahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847025/
https://www.ncbi.nlm.nih.gov/pubmed/36650499
http://dx.doi.org/10.1186/s12943-022-01701-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847025/
https://www.ncbi.nlm.nih.gov/pubmed/36650499
http://dx.doi.org/10.1186/s12943-022-01701-x

Ejemplares similares